Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gemini Therapeutics Inc (NQ: GMTX ) N/A UNCHANGED Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.090 (20) Ask (Size) 1.330 (1) Prev. Close 1.350 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation February 21, 2023 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket December 28, 2022 Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. Via Benzinga Performance More News Read More 7 Short-Squeeze Stocks for Bold Contrarians to Consider November 21, 2022 Via InvestorPlace Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company August 10, 2022 Via Benzinga GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX August 12, 2022 From Kahn Swick & Foti, LLC Via Business Wire GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders August 10, 2022 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session August 10, 2022 Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Via Benzinga Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday August 11, 2022 Via Benzinga Gemini Therapeutics and Disc Medicine Announce Merger Agreement August 10, 2022 From Gemini Therapeutics, Inc. Via Business Wire The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More April 14, 2022 Via Benzinga 10 Biggest Price Target Changes For Friday March 11, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022 March 11, 2022 Via Benzinga What 5 Analyst Ratings Have To Say About Gemini Therapeutics March 03, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 March 03, 2022 Via Benzinga 10 Biggest Price Target Changes For Thursday March 03, 2022 Via Benzinga Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold March 01, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 01, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 March 01, 2022 Via Benzinga 10 Biggest Price Target Changes For Tuesday March 01, 2022 Via Benzinga Gemini Therapeutics Provides Corporate Update February 28, 2022 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics Provides GEM103 Program Update January 10, 2022 From Gemini Therapeutics, Inc. Via Business Wire 46 Biggest Movers From Yesterday December 16, 2021 Via Benzinga Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update December 15, 2021 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 15, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.